Rank | Gene Set | Z-score |
---|---|---|
1 | thrombin receptor signaling pathway (GO:0070493) | 6.21210244 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.90602721 |
3 | regulation of platelet aggregation (GO:0090330) | 5.59539454 |
4 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.42429366 |
5 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.92341898 |
6 | platelet aggregation (GO:0070527) | 4.82688029 |
7 | neutrophil activation involved in immune response (GO:0002283) | 4.67734288 |
8 | regulation of platelet activation (GO:0010543) | 4.61611872 |
9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.57990677 |
10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.57358872 |
11 | definitive hemopoiesis (GO:0060216) | 4.55245593 |
12 | adenosine receptor signaling pathway (GO:0001973) | 4.52682714 |
13 | negative regulation of norepinephrine secretion (GO:0010700) | 4.51133908 |
14 | negative regulation of protein localization to cell surface (GO:2000009) | 4.43847148 |
15 | defense response to protozoan (GO:0042832) | 4.37643272 |
16 | response to interferon-beta (GO:0035456) | 4.36712762 |
17 | negative regulation of platelet activation (GO:0010544) | 4.34021248 |
18 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.03852071 |
19 | cellular response to interferon-beta (GO:0035458) | 4.00391614 |
20 | response to protozoan (GO:0001562) | 3.96799064 |
21 | nerve growth factor signaling pathway (GO:0038180) | 3.95430841 |
22 | positive regulation of mast cell degranulation (GO:0043306) | 3.94981045 |
23 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.94981045 |
24 | iron ion import (GO:0097286) | 3.94654872 |
25 | platelet formation (GO:0030220) | 3.90268918 |
26 | regulation of integrin activation (GO:0033623) | 3.87608642 |
27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.87247684 |
28 | mast cell activation (GO:0045576) | 3.86417671 |
29 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77258585 |
30 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.76017915 |
31 | regulation of early endosome to late endosome transport (GO:2000641) | 3.70259370 |
32 | response to peptidoglycan (GO:0032494) | 3.69905523 |
33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.69028659 |
34 | relaxation of smooth muscle (GO:0044557) | 3.68022696 |
35 | superoxide anion generation (GO:0042554) | 3.66357291 |
36 | respiratory burst (GO:0045730) | 3.65467400 |
37 | relaxation of muscle (GO:0090075) | 3.62664053 |
38 | regulation of mast cell degranulation (GO:0043304) | 3.57629602 |
39 | positive regulation of mast cell activation (GO:0033005) | 3.57579785 |
40 | import into cell (GO:0098657) | 3.56448626 |
41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55761235 |
42 | modulation by symbiont of host defense response (GO:0052031) | 3.55761235 |
43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55761235 |
44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55761235 |
45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55761235 |
46 | modulation by symbiont of host immune response (GO:0052553) | 3.55761235 |
47 | activation of protein kinase A activity (GO:0034199) | 3.53950227 |
48 | platelet degranulation (GO:0002576) | 3.53209654 |
49 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.52636407 |
50 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.51072743 |
51 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.51054472 |
52 | cellular response to zinc ion (GO:0071294) | 3.49129789 |
53 | response to interferon-alpha (GO:0035455) | 3.49031644 |
54 | regulation of skeletal muscle contraction (GO:0014819) | 3.44352246 |
55 | response to type I interferon (GO:0034340) | 3.43748313 |
56 | type I interferon signaling pathway (GO:0060337) | 3.43100155 |
57 | cellular response to type I interferon (GO:0071357) | 3.43100155 |
58 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.41212900 |
59 | linoleic acid metabolic process (GO:0043651) | 3.40761559 |
60 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.39767862 |
61 | platelet dense granule organization (GO:0060155) | 3.39232840 |
62 | neutrophil activation (GO:0042119) | 3.38143669 |
63 | myeloid dendritic cell activation (GO:0001773) | 3.35835175 |
64 | angiogenesis involved in wound healing (GO:0060055) | 3.35833461 |
65 | regulation of mast cell activation (GO:0033003) | 3.32656137 |
66 | regulation of lipoprotein metabolic process (GO:0050746) | 3.26588196 |
67 | regulation of activation of Janus kinase activity (GO:0010533) | 3.26277640 |
68 | positive regulation of steroid hormone secretion (GO:2000833) | 3.25017156 |
69 | positive regulation of B cell differentiation (GO:0045579) | 3.24122687 |
70 | granulocyte activation (GO:0036230) | 3.23454930 |
71 | T-helper 1 type immune response (GO:0042088) | 3.22767272 |
72 | negative regulation of muscle contraction (GO:0045932) | 3.22188237 |
73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19064513 |
74 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.18847088 |
75 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.18694142 |
76 | protein neddylation (GO:0045116) | 3.18222763 |
77 | positive regulation of receptor recycling (GO:0001921) | 3.17985359 |
78 | myeloid cell activation involved in immune response (GO:0002275) | 3.15995049 |
79 | response to thyroid hormone (GO:0097066) | 3.15947770 |
80 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.14520812 |
81 | negative regulation of viral genome replication (GO:0045071) | 3.14515396 |
82 | immunoglobulin mediated immune response (GO:0016064) | 3.13109747 |
83 | histamine transport (GO:0051608) | 3.12211767 |
84 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.11886360 |
85 | platelet activation (GO:0030168) | 3.10748867 |
86 | megakaryocyte development (GO:0035855) | 3.10312372 |
87 | negative regulation of neurotransmitter transport (GO:0051589) | 3.08927270 |
88 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.07323745 |
89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06787947 |
90 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.04430381 |
91 | lipoxygenase pathway (GO:0019372) | 3.03174789 |
92 | myeloid dendritic cell differentiation (GO:0043011) | 3.02478764 |
93 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.02249142 |
94 | positive regulation of muscle hypertrophy (GO:0014742) | 3.02249142 |
95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.02065917 |
96 | positive regulation of granulocyte differentiation (GO:0030854) | 3.01749132 |
97 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.01622062 |
98 | histamine secretion (GO:0001821) | 3.00481982 |
99 | skeletal muscle tissue regeneration (GO:0043403) | 2.99225297 |
100 | negative regulation of interleukin-17 production (GO:0032700) | 2.99077489 |
101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98783090 |
102 | cellular response to exogenous dsRNA (GO:0071360) | 2.97894163 |
103 | extracellular fibril organization (GO:0043206) | 2.97463239 |
104 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.97129064 |
105 | homotypic cell-cell adhesion (GO:0034109) | 2.95127391 |
106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94576304 |
107 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.94381792 |
108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93409924 |
109 | regulation of erythrocyte differentiation (GO:0045646) | 2.91578901 |
110 | Rap protein signal transduction (GO:0032486) | 2.91213553 |
111 | negative regulation of heart contraction (GO:0045822) | 2.89072871 |
112 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88209870 |
113 | actin-myosin filament sliding (GO:0033275) | 2.87509027 |
114 | muscle filament sliding (GO:0030049) | 2.87509027 |
115 | mast cell activation involved in immune response (GO:0002279) | 2.87326333 |
116 | mast cell degranulation (GO:0043303) | 2.87326333 |
117 | dopamine transport (GO:0015872) | 2.86242541 |
118 | response to host immune response (GO:0052572) | 2.85991232 |
119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85991232 |
120 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.83763467 |
121 | fibroblast migration (GO:0010761) | 2.83347326 |
122 | positive regulation of interferon-alpha production (GO:0032727) | 2.82900278 |
123 | phagocytosis, recognition (GO:0006910) | 2.82741787 |
124 | leukocyte degranulation (GO:0043299) | 2.81663961 |
125 | negative regulation of histone methylation (GO:0031061) | 2.81562909 |
126 | cellular response to epinephrine stimulus (GO:0071872) | 2.81390985 |
127 | macrophage activation involved in immune response (GO:0002281) | 2.80544839 |
128 | myeloid leukocyte activation (GO:0002274) | 2.77861303 |
129 | myeloid cell development (GO:0061515) | 2.77506305 |
130 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.76969588 |
131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76201043 |
132 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.75731080 |
133 | gas transport (GO:0015669) | 2.74893085 |
134 | detection of other organism (GO:0098543) | 2.74517963 |
135 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.74146403 |
136 | oxygen transport (GO:0015671) | 2.73949861 |
137 | response to muramyl dipeptide (GO:0032495) | 2.73839585 |
138 | eosinophil chemotaxis (GO:0048245) | 2.71569050 |
139 | interkinetic nuclear migration (GO:0022027) | 2.71507498 |
140 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.71450216 |
141 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.71398688 |
142 | granulocyte differentiation (GO:0030851) | 2.70886565 |
143 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.70492340 |
144 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.69474863 |
145 | mesodermal cell differentiation (GO:0048333) | 2.69199730 |
146 | phagocytosis, engulfment (GO:0006911) | 2.68521071 |
147 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.66987169 |
148 | regulation of antigen processing and presentation (GO:0002577) | 2.66553592 |
149 | lymphoid progenitor cell differentiation (GO:0002320) | 2.64783550 |
150 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.64265828 |
151 | polyamine biosynthetic process (GO:0006596) | 2.64072968 |
152 | ribosomal small subunit assembly (GO:0000028) | 2.63956860 |
153 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.63866056 |
154 | regulation of chemokine biosynthetic process (GO:0045073) | 2.63740866 |
155 | regulation of interferon-alpha production (GO:0032647) | 2.62342218 |
156 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61875245 |
157 | hypotonic response (GO:0006971) | 2.61823935 |
158 | phospholipid scrambling (GO:0017121) | 2.61744812 |
159 | toxin transport (GO:1901998) | 2.60709682 |
160 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60652567 |
161 | regulation of interleukin-17 production (GO:0032660) | 2.60111459 |
162 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59409721 |
163 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.58781713 |
164 | positive regulation of vasculogenesis (GO:2001214) | 2.58657935 |
165 | detection of molecule of bacterial origin (GO:0032490) | 2.58346219 |
166 | autophagic vacuole fusion (GO:0000046) | 2.58290955 |
167 | regulation of B cell differentiation (GO:0045577) | 2.58251167 |
168 | response to epinephrine (GO:0071871) | 2.57639883 |
169 | mature B cell differentiation (GO:0002335) | 2.56887051 |
170 | creatine metabolic process (GO:0006600) | 2.56843535 |
171 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.56827544 |
172 | positive regulation of interleukin-12 production (GO:0032735) | 2.56368126 |
173 | fibril organization (GO:0097435) | 2.56244240 |
174 | regulation of hypersensitivity (GO:0002883) | 2.55656185 |
175 | positive regulation of p38MAPK cascade (GO:1900745) | 2.54299426 |
176 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54214954 |
177 | positive regulation of interleukin-17 production (GO:0032740) | 2.53919792 |
178 | positive regulation of lymphocyte migration (GO:2000403) | 2.53881167 |
179 | positive regulation of interleukin-10 production (GO:0032733) | 2.53584024 |
180 | regulation of natural killer cell differentiation (GO:0032823) | 2.52618594 |
181 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.51803088 |
182 | daunorubicin metabolic process (GO:0044597) | 2.51725117 |
183 | doxorubicin metabolic process (GO:0044598) | 2.51725117 |
184 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.51502496 |
185 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.50592396 |
186 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.49095572 |
187 | cGMP-mediated signaling (GO:0019934) | 2.46423701 |
188 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45953158 |
189 | negative regulation of catecholamine secretion (GO:0033604) | 2.45039408 |
190 | muscle cell fate commitment (GO:0042693) | 2.44917429 |
191 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.44351702 |
192 | beta-amyloid metabolic process (GO:0050435) | 2.42228506 |
193 | myofibril assembly (GO:0030239) | 2.41352566 |
194 | negative regulation of heart rate (GO:0010459) | 2.40198566 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.10665272 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.54222005 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.98703803 |
4 | GATA1_19941826_ChIP-Seq_K562_Human | 4.39045803 |
5 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.00531380 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.94673419 |
7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.77996436 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.47125710 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.35829695 |
10 | * GATA2_19941826_ChIP-Seq_K562_Human | 3.33271383 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01567035 |
12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.96324857 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92343600 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88822398 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81886944 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79305411 |
17 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.79159153 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.73138569 |
19 | NCOR1_26117541_ChIP-Seq_K562_Human | 2.52584187 |
20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48200065 |
21 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.35592028 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27485195 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23335156 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20910535 |
25 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20175899 |
26 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20121005 |
27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16009878 |
28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.13468995 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10112726 |
30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03789979 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01673854 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00188948 |
33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98328951 |
34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97084549 |
35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.92672055 |
36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.84211388 |
37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82413311 |
38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73661412 |
39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72677911 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69773467 |
41 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.68854543 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68471572 |
43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66116169 |
44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65648473 |
45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65191847 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61785558 |
47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59675535 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59040737 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55294029 |
50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53413517 |
51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52116351 |
52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51181371 |
53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50022253 |
54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48360259 |
55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45951642 |
56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44477020 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44469387 |
58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44266588 |
59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44202783 |
60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40925225 |
61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40174333 |
62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39789266 |
63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38796898 |
64 | MYC_22102868_ChIP-Seq_BL_Human | 1.36761799 |
65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33374318 |
66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31661392 |
67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31374306 |
68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30740668 |
69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30686386 |
70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29438601 |
71 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29172431 |
72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26485653 |
73 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26188325 |
74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26018619 |
75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25742161 |
76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22509188 |
77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21620771 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17932463 |
79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17786631 |
80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15965444 |
81 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15700334 |
82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15477215 |
83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15138946 |
84 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14270157 |
85 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13737740 |
86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13538141 |
87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11767299 |
88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11655597 |
89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10508713 |
90 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10125085 |
91 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09853905 |
92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09535548 |
93 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.09434206 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08122829 |
95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07619472 |
96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07554909 |
97 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07185508 |
98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.07152111 |
99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07042064 |
100 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06859532 |
101 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04482751 |
102 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.03710249 |
103 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03706636 |
104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03146159 |
105 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02968181 |
106 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02835879 |
107 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02304250 |
108 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02292581 |
109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02005521 |
110 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.01964160 |
111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01740352 |
112 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01469295 |
113 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01455150 |
114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00906472 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00289683 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00218078 |
117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00128336 |
118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00091706 |
119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00017018 |
120 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00017018 |
121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99321529 |
122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97812290 |
123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97780941 |
124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97369823 |
125 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96720903 |
126 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96274660 |
127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95985221 |
128 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95974929 |
129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95517444 |
130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95517444 |
131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95442140 |
132 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95003393 |
133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94452822 |
134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93964118 |
135 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.93303104 |
136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93298219 |
137 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93183982 |
138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93067232 |
139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92174662 |
140 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91684327 |
141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91676745 |
142 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91550797 |
143 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91506395 |
144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91388641 |
145 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90882187 |
146 | MYB_26560356_Chip-Seq_TH2_Human | 0.90341557 |
147 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90340415 |
148 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89861113 |
149 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89722801 |
150 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89646783 |
151 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88990439 |
152 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88147464 |
153 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88072297 |
154 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87536366 |
155 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.87412062 |
156 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.85864324 |
157 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84998875 |
158 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84622904 |
159 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84583711 |
160 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84536905 |
161 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84128238 |
162 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83490534 |
163 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82359396 |
164 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81575116 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008004_abnormal_stomach_pH | 5.06788952 |
2 | MP0004084_abnormal_cardiac_muscle | 4.29920350 |
3 | MP0001835_abnormal_antigen_presentation | 4.14667549 |
4 | MP0004036_abnormal_muscle_relaxation | 4.01569158 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.70985101 |
6 | MP0004145_abnormal_muscle_electrophysio | 3.58448562 |
7 | MP0009785_altered_susceptibility_to | 3.36301451 |
8 | MP0003724_increased_susceptibility_to | 3.05897001 |
9 | MP0002419_abnormal_innate_immunity | 2.82539303 |
10 | MP0005464_abnormal_platelet_physiology | 2.79670636 |
11 | MP0005025_abnormal_response_to | 2.71380293 |
12 | MP0003436_decreased_susceptibility_to | 2.70161870 |
13 | MP0005000_abnormal_immune_tolerance | 2.65892804 |
14 | MP0003195_calcinosis | 2.54648462 |
15 | MP0005671_abnormal_response_to | 2.54093814 |
16 | MP0005174_abnormal_tail_pigmentation | 2.53974680 |
17 | MP0008775_abnormal_heart_ventricle | 2.48121213 |
18 | MP0004510_myositis | 2.36192954 |
19 | MP0005387_immune_system_phenotype | 2.35299744 |
20 | MP0001790_abnormal_immune_system | 2.35299744 |
21 | MP0002452_abnormal_antigen_presenting | 2.24833127 |
22 | MP0006082_CNS_inflammation | 2.24296805 |
23 | MP0000685_abnormal_immune_system | 2.21823465 |
24 | MP0003566_abnormal_cell_adhesion | 2.19836647 |
25 | MP0002723_abnormal_immune_serum | 2.17829694 |
26 | MP0001800_abnormal_humoral_immune | 2.07543002 |
27 | MP0005451_abnormal_body_composition | 2.06712461 |
28 | MP0003303_peritoneal_inflammation | 2.06024332 |
29 | MP0003705_abnormal_hypodermis_morpholog | 2.05134398 |
30 | MP0001819_abnormal_immune_cell | 1.96845514 |
31 | MP0002420_abnormal_adaptive_immunity | 1.94659984 |
32 | MP0001853_heart_inflammation | 1.94048762 |
33 | MP0009764_decreased_sensitivity_to | 1.91438258 |
34 | MP0000015_abnormal_ear_pigmentation | 1.85677786 |
35 | MP0004130_abnormal_muscle_cell | 1.83606486 |
36 | MP0005670_abnormal_white_adipose | 1.81838695 |
37 | MP0001188_hyperpigmentation | 1.75993668 |
38 | MP0000230_abnormal_systemic_arterial | 1.75920649 |
39 | MP0002006_tumorigenesis | 1.74931792 |
40 | MP0001545_abnormal_hematopoietic_system | 1.74077381 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.74077381 |
42 | MP0005666_abnormal_adipose_tissue | 1.72527891 |
43 | MP0006138_congestive_heart_failure | 1.68167976 |
44 | MP0005310_abnormal_salivary_gland | 1.63603089 |
45 | MP0002166_altered_tumor_susceptibility | 1.60448406 |
46 | MP0005620_abnormal_muscle_contractility | 1.59771519 |
47 | MP0004808_abnormal_hematopoietic_stem | 1.58419166 |
48 | MP0001845_abnormal_inflammatory_respons | 1.52351663 |
49 | MP0002972_abnormal_cardiac_muscle | 1.51063443 |
50 | MP0003879_abnormal_hair_cell | 1.50872855 |
51 | MP0010155_abnormal_intestine_physiology | 1.49681623 |
52 | MP0003075_altered_response_to | 1.48911212 |
53 | MP0003300_gastrointestinal_ulcer | 1.48038808 |
54 | MP0005083_abnormal_biliary_tract | 1.47222781 |
55 | MP0004215_abnormal_myocardial_fiber | 1.45223520 |
56 | MP0004233_abnormal_muscle_weight | 1.45159102 |
57 | MP0001661_extended_life_span | 1.41813216 |
58 | MP0002398_abnormal_bone_marrow | 1.41085839 |
59 | MP0003045_fibrosis | 1.40748675 |
60 | MP0008469_abnormal_protein_level | 1.40712801 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.40421562 |
62 | MP0002396_abnormal_hematopoietic_system | 1.38287038 |
63 | MP0000716_abnormal_immune_system | 1.38192995 |
64 | MP0005409_darkened_coat_color | 1.36057676 |
65 | MP0001544_abnormal_cardiovascular_syste | 1.35676031 |
66 | MP0005385_cardiovascular_system_phenoty | 1.35676031 |
67 | MP0003828_pulmonary_edema | 1.34127408 |
68 | MP0001533_abnormal_skeleton_physiology | 1.33251120 |
69 | MP0001879_abnormal_lymphatic_vessel | 1.32900632 |
70 | MP0000343_altered_response_to | 1.32567030 |
71 | MP0002405_respiratory_system_inflammati | 1.32048271 |
72 | MP0002095_abnormal_skin_pigmentation | 1.29909610 |
73 | MP0004087_abnormal_muscle_fiber | 1.29526859 |
74 | MP0002998_abnormal_bone_remodeling | 1.27133251 |
75 | MP0009697_abnormal_copulation | 1.25871656 |
76 | MP0000747_muscle_weakness | 1.25766858 |
77 | MP0005647_abnormal_sex_gland | 1.24223892 |
78 | MP0002009_preneoplasia | 1.22146250 |
79 | MP0000569_abnormal_digit_pigmentation | 1.19696167 |
80 | MP0003279_aneurysm | 1.19443083 |
81 | MP0005171_absent_coat_pigmentation | 1.17022765 |
82 | MP0000749_muscle_degeneration | 1.15237772 |
83 | MP0005075_abnormal_melanosome_morpholog | 1.14935617 |
84 | MP0000689_abnormal_spleen_morphology | 1.14469694 |
85 | MP0004947_skin_inflammation | 1.14344890 |
86 | MP0005058_abnormal_lysosome_morphology | 1.14324156 |
87 | MP0005167_abnormal_blood-brain_barrier | 1.13000423 |
88 | MP0003646_muscle_fatigue | 1.12335364 |
89 | MP0005379_endocrine/exocrine_gland_phen | 1.12187077 |
90 | MP0002429_abnormal_blood_cell | 1.12038504 |
91 | MP0004147_increased_porphyrin_level | 1.11479714 |
92 | MP0010630_abnormal_cardiac_muscle | 1.11298937 |
93 | MP0001986_abnormal_taste_sensitivity | 1.11170553 |
94 | MP0003091_abnormal_cell_migration | 1.11149546 |
95 | MP0002132_abnormal_respiratory_system | 1.11055101 |
96 | MP0002837_dystrophic_cardiac_calcinosis | 1.10951634 |
97 | MP0003950_abnormal_plasma_membrane | 1.10811450 |
98 | MP0002128_abnormal_blood_circulation | 1.10474595 |
99 | MP0002106_abnormal_muscle_physiology | 1.10342902 |
100 | MP0005166_decreased_susceptibility_to | 1.08900643 |
101 | MP0005330_cardiomyopathy | 1.08742181 |
102 | MP0005275_abnormal_skin_tensile | 1.07981616 |
103 | MP0005646_abnormal_pituitary_gland | 1.07627026 |
104 | MP0005375_adipose_tissue_phenotype | 1.06854142 |
105 | MP0003656_abnormal_erythrocyte_physiolo | 1.05426401 |
106 | MP0000372_irregular_coat_pigmentation | 1.04496519 |
107 | MP0002332_abnormal_exercise_endurance | 1.03094115 |
108 | MP0010386_abnormal_urinary_bladder | 1.03005663 |
109 | MP0000767_abnormal_smooth_muscle | 1.01948492 |
110 | MP0004272_abnormal_basement_membrane | 1.01037358 |
111 | MP0000751_myopathy | 1.00406984 |
112 | MP0000759_abnormal_skeletal_muscle | 1.00225900 |
113 | MP0003690_abnormal_glial_cell | 0.99329128 |
114 | MP0002722_abnormal_immune_system | 0.99313764 |
115 | MP0003448_altered_tumor_morphology | 0.99268533 |
116 | MP0009278_abnormal_bone_marrow | 0.98484785 |
117 | MP0004484_altered_response_of | 0.98164666 |
118 | MP0006292_abnormal_olfactory_placode | 0.98103758 |
119 | MP0004782_abnormal_surfactant_physiolog | 0.97955806 |
120 | MP0009763_increased_sensitivity_to | 0.95586188 |
121 | MP0004883_abnormal_blood_vessel | 0.94758585 |
122 | MP0002269_muscular_atrophy | 0.92581128 |
123 | MP0008438_abnormal_cutaneous_collagen | 0.92426606 |
124 | MP0003866_abnormal_defecation | 0.90760056 |
125 | MP0002877_abnormal_melanocyte_morpholog | 0.89782682 |
126 | MP0004085_abnormal_heartbeat | 0.89125020 |
127 | MP0005164_abnormal_response_to | 0.89091356 |
128 | MP0000681_abnormal_thyroid_gland | 0.88919419 |
129 | MP0009765_abnormal_xenobiotic_induced | 0.88895594 |
130 | MP0002277_abnormal_respiratory_mucosa | 0.88867186 |
131 | MP0005369_muscle_phenotype | 0.88705245 |
132 | MP0004134_abnormal_chest_morphology | 0.88483700 |
133 | MP0005503_abnormal_tendon_morphology | 0.88347567 |
134 | MP0002933_joint_inflammation | 0.87860114 |
135 | MP0008260_abnormal_autophagy | 0.87090469 |
136 | MP0003172_abnormal_lysosome_physiology | 0.85711134 |
137 | MP0001958_emphysema | 0.85172078 |
138 | MP0000249_abnormal_blood_vessel | 0.82977288 |
139 | MP0004185_abnormal_adipocyte_glucose | 0.80687752 |
140 | MP0000858_altered_metastatic_potential | 0.80482310 |
141 | MP0004858_abnormal_nervous_system | 0.80170232 |
142 | MP0005535_abnormal_body_temperature | 0.77848250 |
143 | MP0005595_abnormal_vascular_smooth | 0.77765503 |
144 | MP0009333_abnormal_splenocyte_physiolog | 0.74510435 |
145 | MP0005390_skeleton_phenotype | 0.72669403 |
146 | MP0001851_eye_inflammation | 0.72090599 |
147 | MP0000920_abnormal_myelination | 0.71856274 |
148 | MP0009379_abnormal_foot_pigmentation | 0.70506768 |
149 | MP0003763_abnormal_thymus_physiology | 0.69666743 |
150 | MP0000266_abnormal_heart_morphology | 0.67985554 |
151 | MP0008961_abnormal_basal_metabolism | 0.67776772 |
152 | MP0001764_abnormal_homeostasis | 0.67522886 |
153 | MP0001664_abnormal_digestion | 0.67264444 |
154 | MP0005645_abnormal_hypothalamus_physiol | 0.67164084 |
155 | MP0005410_abnormal_fertilization | 0.66215005 |
156 | MP0003638_abnormal_response/metabolism_ | 0.65995097 |
157 | MP0005187_abnormal_penis_morphology | 0.65306340 |
158 | MP0003183_abnormal_peptide_metabolism | 0.65027870 |
159 | MP0002108_abnormal_muscle_morphology | 0.64964808 |
160 | MP0003959_abnormal_lean_body | 0.64737040 |
161 | MP0001614_abnormal_blood_vessel | 0.64634657 |
162 | MP0002876_abnormal_thyroid_physiology | 0.64050886 |
163 | MP0005023_abnormal_wound_healing | 0.61421819 |
164 | MP0001663_abnormal_digestive_system | 0.61144322 |
165 | MP0002925_abnormal_cardiovascular_devel | 0.60476144 |
166 | MP0005076_abnormal_cell_differentiation | 0.59566210 |
167 | MP0002971_abnormal_brown_adipose | 0.59143655 |
168 | MP0009642_abnormal_blood_homeostasis | 0.58749013 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.75938155 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.37242332 |
3 | Prolonged bleeding time (HP:0003010) | 4.48026311 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.46002377 |
5 | Eczematoid dermatitis (HP:0000976) | 4.33574334 |
6 | Aortic aneurysm (HP:0004942) | 4.24381805 |
7 | Acanthocytosis (HP:0001927) | 4.18874752 |
8 | Hyperthyroidism (HP:0000836) | 4.14264921 |
9 | Poikilocytosis (HP:0004447) | 4.12585754 |
10 | Abnormality of macrophages (HP:0004311) | 4.06046344 |
11 | Petechiae (HP:0000967) | 3.98616906 |
12 | Myositis (HP:0100614) | 3.69671369 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.68655512 |
14 | Exercise-induced myalgia (HP:0003738) | 3.67963080 |
15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66422497 |
16 | Polycythemia (HP:0001901) | 3.52595389 |
17 | Hyperlipoproteinemia (HP:0010980) | 3.50120879 |
18 | Recurrent skin infections (HP:0001581) | 3.44768547 |
19 | Prostate neoplasm (HP:0100787) | 3.43681853 |
20 | Gingival bleeding (HP:0000225) | 3.38477747 |
21 | Purpura (HP:0000979) | 3.37927387 |
22 | Autoimmune thrombocytopenia (HP:0001973) | 3.35436045 |
23 | Vacuolated lymphocytes (HP:0001922) | 3.32221160 |
24 | Calf muscle hypertrophy (HP:0008981) | 3.31447304 |
25 | Patchy hypopigmentation of hair (HP:0011365) | 3.29197063 |
26 | Retrobulbar optic neuritis (HP:0100654) | 3.28640053 |
27 | Optic neuritis (HP:0100653) | 3.28640053 |
28 | Vasculitis (HP:0002633) | 3.17181277 |
29 | Epistaxis (HP:0000421) | 3.16996583 |
30 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.16923536 |
31 | Orchitis (HP:0100796) | 3.16558188 |
32 | Increased IgM level (HP:0003496) | 3.13007329 |
33 | Truncus arteriosus (HP:0001660) | 3.11939367 |
34 | Recurrent fungal infections (HP:0002841) | 3.05473263 |
35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97916616 |
36 | White forelock (HP:0002211) | 2.97207632 |
37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96590806 |
38 | Obstructive lung disease (HP:0006536) | 2.96590806 |
39 | Nemaline bodies (HP:0003798) | 2.95806354 |
40 | Muscle fiber inclusion bodies (HP:0100299) | 2.93996536 |
41 | Type 1 muscle fiber predominance (HP:0003803) | 2.93523119 |
42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.90444536 |
43 | Menorrhagia (HP:0000132) | 2.83476781 |
44 | Cellulitis (HP:0100658) | 2.79579185 |
45 | Gingivitis (HP:0000230) | 2.74783722 |
46 | Meningitis (HP:0001287) | 2.72810833 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72586972 |
48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72586972 |
49 | Hypothermia (HP:0002045) | 2.72583654 |
50 | Increased cerebral lipofuscin (HP:0011813) | 2.70748276 |
51 | Recurrent viral infections (HP:0004429) | 2.70218132 |
52 | Thrombocytosis (HP:0001894) | 2.65637908 |
53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.65239144 |
54 | Conjunctival telangiectasia (HP:0000524) | 2.63972533 |
55 | IgM deficiency (HP:0002850) | 2.63724400 |
56 | Basal ganglia calcification (HP:0002135) | 2.63481875 |
57 | Gastrointestinal stroma tumor (HP:0100723) | 2.60071082 |
58 | Abnormality of the fingertips (HP:0001211) | 2.59099338 |
59 | Abnormal large intestine physiology (HP:0012700) | 2.58799988 |
60 | Cholecystitis (HP:0001082) | 2.56362656 |
61 | Abnormal gallbladder physiology (HP:0012438) | 2.56362656 |
62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.56097724 |
63 | Abnormal platelet volume (HP:0011876) | 2.56046503 |
64 | Seborrheic dermatitis (HP:0001051) | 2.55434786 |
65 | Dysmetric saccades (HP:0000641) | 2.55197672 |
66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.52420051 |
67 | Stomatitis (HP:0010280) | 2.51095171 |
68 | Bowel incontinence (HP:0002607) | 2.48187197 |
69 | Periodontitis (HP:0000704) | 2.47839893 |
70 | Abnormality of the prostate (HP:0008775) | 2.45688933 |
71 | Joint hemorrhage (HP:0005261) | 2.45535229 |
72 | Impaired platelet aggregation (HP:0003540) | 2.43073420 |
73 | Abnormal platelet function (HP:0011869) | 2.43073420 |
74 | Pulmonary artery stenosis (HP:0004415) | 2.40990236 |
75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.40094750 |
76 | Urticaria (HP:0001025) | 2.39285632 |
77 | Hyporeflexia of lower limbs (HP:0002600) | 2.35295489 |
78 | Chronic otitis media (HP:0000389) | 2.33154908 |
79 | Recurrent pneumonia (HP:0006532) | 2.32471384 |
80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31828577 |
81 | Increased connective tissue (HP:0009025) | 2.29216876 |
82 | Reduced antithrombin III activity (HP:0001976) | 2.28272828 |
83 | Spontaneous hematomas (HP:0007420) | 2.27065197 |
84 | Ventricular fibrillation (HP:0001663) | 2.27018787 |
85 | Ankyloglossia (HP:0010296) | 2.26108300 |
86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25115571 |
87 | Interstitial pulmonary disease (HP:0006530) | 2.24476843 |
88 | Abnormal pupillary function (HP:0007686) | 2.24394068 |
89 | Systemic lupus erythematosus (HP:0002725) | 2.23571717 |
90 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23229543 |
91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22088483 |
92 | Atelectasis (HP:0100750) | 2.21025028 |
93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20841824 |
94 | Keratoconjunctivitis sicca (HP:0001097) | 2.20320761 |
95 | Abnormality of the calf musculature (HP:0001430) | 2.18709094 |
96 | Reticulocytosis (HP:0001923) | 2.18666930 |
97 | Myocardial infarction (HP:0001658) | 2.18405010 |
98 | Muscle fiber splitting (HP:0003555) | 2.18229781 |
99 | Tinnitus (HP:0000360) | 2.17547152 |
100 | Paralysis (HP:0003470) | 2.16276860 |
101 | Axonal loss (HP:0003447) | 2.14660400 |
102 | Papillary thyroid carcinoma (HP:0002895) | 2.13816017 |
103 | Upper limb muscle weakness (HP:0003484) | 2.13769350 |
104 | Chronic sinusitis (HP:0011109) | 2.11708788 |
105 | Agammaglobulinemia (HP:0004432) | 2.11036271 |
106 | Hypertensive crisis (HP:0100735) | 2.10158373 |
107 | Pulmonary infiltrates (HP:0002113) | 2.09857923 |
108 | Abnormality of the tricuspid valve (HP:0001702) | 2.09240216 |
109 | Testicular neoplasm (HP:0010788) | 2.09216860 |
110 | Increased mean platelet volume (HP:0011877) | 2.08809246 |
111 | Bulbar palsy (HP:0001283) | 2.08442917 |
112 | Arterial thrombosis (HP:0004420) | 2.07284908 |
113 | Subaortic stenosis (HP:0001682) | 2.07080280 |
114 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07080280 |
115 | Venous insufficiency (HP:0005293) | 2.06767210 |
116 | Persistence of primary teeth (HP:0006335) | 2.05885508 |
117 | Venous abnormality (HP:0002624) | 2.03635377 |
118 | Albinism (HP:0001022) | 2.02184252 |
119 | Hypergammaglobulinemia (HP:0010702) | 1.99178599 |
120 | Bundle branch block (HP:0011710) | 1.99168753 |
121 | Glomerulonephritis (HP:0000099) | 1.99120029 |
122 | Encephalitis (HP:0002383) | 1.98553604 |
123 | Hemoptysis (HP:0002105) | 1.97971929 |
124 | Keratoconjunctivitis (HP:0001096) | 1.97088103 |
125 | Acute myeloid leukemia (HP:0004808) | 1.96241353 |
126 | Aortic dissection (HP:0002647) | 1.95347488 |
127 | Abnormality of lateral ventricle (HP:0030047) | 1.94409704 |
128 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94170145 |
129 | Myopathic facies (HP:0002058) | 1.93017940 |
130 | Neutropenia (HP:0001875) | 1.92258626 |
131 | Leukocytosis (HP:0001974) | 1.91757910 |
132 | Neoplasm of head and neck (HP:0012288) | 1.90767087 |
133 | Esophageal neoplasm (HP:0100751) | 1.90767087 |
134 | Spinal cord lesions (HP:0100561) | 1.90389001 |
135 | Syringomyelia (HP:0003396) | 1.90389001 |
136 | Nausea (HP:0002018) | 1.90300075 |
137 | Sudden death (HP:0001699) | 1.89953346 |
138 | Tetraparesis (HP:0002273) | 1.89579884 |
139 | Distal lower limb amyotrophy (HP:0008944) | 1.88684764 |
140 | Dyschromatopsia (HP:0007641) | 1.86273626 |
141 | Bruising susceptibility (HP:0000978) | 1.84880044 |
142 | Type I transferrin isoform profile (HP:0003642) | 1.83360630 |
143 | Papilledema (HP:0001085) | 1.82640991 |
144 | Osteomyelitis (HP:0002754) | 1.82320970 |
145 | Heterochromia iridis (HP:0001100) | 1.82059031 |
146 | Ileus (HP:0002595) | 1.81867841 |
147 | Hypokinesia (HP:0002375) | 1.80525722 |
148 | Amaurosis fugax (HP:0100576) | 1.80436680 |
149 | Poor head control (HP:0002421) | 1.79596707 |
150 | Microcytic anemia (HP:0001935) | 1.79391751 |
151 | Aortic valve stenosis (HP:0001650) | 1.78919658 |
152 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78578253 |
153 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78578253 |
154 | Abnormal protein glycosylation (HP:0012346) | 1.78578253 |
155 | Abnormal glycosylation (HP:0012345) | 1.78578253 |
156 | Relative macrocephaly (HP:0004482) | 1.78159097 |
157 | Abnormality of T cell physiology (HP:0011840) | 1.77868459 |
158 | Premature loss of primary teeth (HP:0006323) | 1.77453984 |
159 | Bone pain (HP:0002653) | 1.77225091 |
160 | Gastrointestinal dysmotility (HP:0002579) | 1.74586837 |
161 | Aneurysm (HP:0002617) | 1.73487105 |
162 | Myoglobinuria (HP:0002913) | 1.68973216 |
163 | Exercise-induced muscle cramps (HP:0003710) | 1.68221204 |
164 | Increased density of long bones (HP:0006392) | 1.66907597 |
165 | Gonadotropin excess (HP:0000837) | 1.66195796 |
166 | Spinal rigidity (HP:0003306) | 1.65889640 |
167 | Overgrowth (HP:0001548) | 1.59185220 |
168 | Thyroid carcinoma (HP:0002890) | 1.57993726 |
169 | Termporal pattern (HP:0011008) | 1.57287050 |
170 | Insidious onset (HP:0003587) | 1.57287050 |
171 | Asymmetric septal hypertrophy (HP:0001670) | 1.57276821 |
172 | Hypoparathyroidism (HP:0000829) | 1.55667868 |
173 | Lipoatrophy (HP:0100578) | 1.50157831 |
174 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.48721950 |
175 | Prolonged QT interval (HP:0001657) | 1.48466186 |
176 | Abnormality of oral frenula (HP:0000190) | 1.45690141 |
177 | Azoospermia (HP:0000027) | 1.42840975 |
178 | Distal lower limb muscle weakness (HP:0009053) | 1.42464671 |
179 | Male infertility (HP:0003251) | 1.42154465 |
180 | Colitis (HP:0002583) | 1.41991996 |
181 | Joint swelling (HP:0001386) | 1.40626751 |
182 | Cholelithiasis (HP:0001081) | 1.39074970 |
183 | Disproportionate tall stature (HP:0001519) | 1.38995318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | AKT3 | 3.96702336 |
2 | KIT | 3.41667497 |
3 | MAP3K14 | 3.37272332 |
4 | TXK | 3.27277162 |
5 | IRAK4 | 3.24884972 |
6 | EEF2K | 2.91863353 |
7 | MYLK | 2.86042773 |
8 | RIPK4 | 2.57537784 |
9 | IRAK3 | 2.53150058 |
10 | BMX | 2.42652354 |
11 | CAMK1D | 2.41782786 |
12 | MAP4K1 | 2.40133550 |
13 | CAMK1G | 2.34882126 |
14 | EIF2AK1 | 2.33864627 |
15 | TBK1 | 2.33090850 |
16 | IKBKE | 2.21361953 |
17 | MAP3K12 | 2.19227289 |
18 | MAP3K13 | 2.10105914 |
19 | BLK | 2.04475009 |
20 | MUSK | 2.03970774 |
21 | DMPK | 1.96761809 |
22 | IKBKB | 1.95080594 |
23 | KSR2 | 1.92183102 |
24 | TAOK3 | 1.90480971 |
25 | TEC | 1.85163083 |
26 | TNK2 | 1.82477555 |
27 | BTK | 1.82073292 |
28 | TIE1 | 1.79104512 |
29 | MATK | 1.77519858 |
30 | TRPM7 | 1.75194238 |
31 | JAK3 | 1.70073933 |
32 | ZAK | 1.69829795 |
33 | RAF1 | 1.67437515 |
34 | STK3 | 1.61512378 |
35 | MAPKAPK3 | 1.61296106 |
36 | PIM2 | 1.59006034 |
37 | PIK3CG | 1.57984231 |
38 | NME2 | 1.57872649 |
39 | ADRBK2 | 1.54160643 |
40 | LATS1 | 1.51170250 |
41 | PBK | 1.50699447 |
42 | SYK | 1.47753279 |
43 | FER | 1.45231668 |
44 | TNIK | 1.42354116 |
45 | ZAP70 | 1.36214913 |
46 | TYK2 | 1.35386681 |
47 | PKN2 | 1.34800680 |
48 | FES | 1.34570109 |
49 | TTN | 1.32483388 |
50 | MAPKAPK5 | 1.31644609 |
51 | CHUK | 1.28908060 |
52 | TRIB3 | 1.27200806 |
53 | ILK | 1.25907556 |
54 | NEK9 | 1.25623997 |
55 | LYN | 1.25623926 |
56 | TGFBR2 | 1.24710917 |
57 | PRKD3 | 1.23067771 |
58 | STK16 | 1.17175915 |
59 | PTK2B | 1.16206620 |
60 | PAK2 | 1.16013963 |
61 | MAPK12 | 1.11987588 |
62 | PIK3CA | 1.11616194 |
63 | RET | 1.10222339 |
64 | MAP3K2 | 1.07806850 |
65 | YES1 | 1.07227793 |
66 | BMPR2 | 1.04507809 |
67 | MARK2 | 1.01488969 |
68 | EIF2AK2 | 1.01376326 |
69 | JAK1 | 0.98546692 |
70 | CASK | 0.97738802 |
71 | VRK1 | 0.91984037 |
72 | MST4 | 0.91157535 |
73 | GRK7 | 0.88172198 |
74 | CSF1R | 0.87974557 |
75 | PIM1 | 0.87779570 |
76 | TAOK1 | 0.86746694 |
77 | LATS2 | 0.86625996 |
78 | STK24 | 0.86001237 |
79 | ABL2 | 0.85724266 |
80 | MAP2K1 | 0.85670529 |
81 | PDGFRA | 0.85609863 |
82 | HCK | 0.84922775 |
83 | PRKD2 | 0.84739814 |
84 | CDC42BPA | 0.84649410 |
85 | LCK | 0.83948456 |
86 | EPHA3 | 0.82796086 |
87 | PRKAA2 | 0.82406938 |
88 | CLK1 | 0.79995898 |
89 | PDPK1 | 0.79623181 |
90 | NEK6 | 0.79206691 |
91 | INSRR | 0.76794958 |
92 | DDR2 | 0.76696162 |
93 | MKNK1 | 0.76248414 |
94 | MAP2K3 | 0.73389581 |
95 | PAK1 | 0.73223327 |
96 | JAK2 | 0.71490456 |
97 | NUAK1 | 0.70881796 |
98 | MAP3K7 | 0.68930187 |
99 | CDK12 | 0.68651759 |
100 | SIK3 | 0.66702138 |
101 | DAPK3 | 0.64240555 |
102 | GRK5 | 0.64233848 |
103 | ICK | 0.64107289 |
104 | RPS6KA4 | 0.63420239 |
105 | MTOR | 0.63236925 |
106 | PRKD1 | 0.62242254 |
107 | PDGFRB | 0.61986690 |
108 | CSK | 0.61272355 |
109 | CCNB1 | 0.60039338 |
110 | STK4 | 0.59842222 |
111 | KSR1 | 0.59146459 |
112 | SIK1 | 0.58481422 |
113 | MAP3K1 | 0.57316537 |
114 | ERN1 | 0.56220092 |
115 | ERBB3 | 0.55184903 |
116 | PRKCQ | 0.54073729 |
117 | SGK2 | 0.53399936 |
118 | MKNK2 | 0.52469765 |
119 | GRK1 | 0.51925732 |
120 | PRKCE | 0.51273878 |
121 | PRKCD | 0.49259314 |
122 | PRKACG | 0.48703250 |
123 | RPS6KA6 | 0.47494197 |
124 | ABL1 | 0.46692945 |
125 | HIPK2 | 0.46435164 |
126 | PHKG1 | 0.45190116 |
127 | PHKG2 | 0.45190116 |
128 | MAP3K6 | 0.43652527 |
129 | WNK1 | 0.43233262 |
130 | PRKG2 | 0.42254121 |
131 | NLK | 0.41316875 |
132 | BRSK2 | 0.41282566 |
133 | CAMK1 | 0.40713866 |
134 | MAP3K5 | 0.40290314 |
135 | ROCK1 | 0.39664773 |
136 | CAMKK2 | 0.38798404 |
137 | TAOK2 | 0.36704597 |
138 | EGFR | 0.36703925 |
139 | IRAK1 | 0.35624819 |
140 | FGFR3 | 0.31156540 |
141 | RPS6KA5 | 0.30566544 |
142 | SGK3 | 0.30359595 |
143 | IRAK2 | 0.29927712 |
144 | MAPK15 | 0.29282056 |
145 | RPS6KC1 | 0.29102757 |
146 | RPS6KL1 | 0.29102757 |
147 | IGF1R | 0.29014995 |
148 | BRAF | 0.28773547 |
149 | PRKAA1 | 0.28742058 |
150 | MAPKAPK2 | 0.28325506 |
151 | ARAF | 0.28231011 |
152 | MAPK3 | 0.27967267 |
153 | MAPK4 | 0.26360514 |
154 | PRKG1 | 0.26309612 |
155 | PDK1 | 0.25832184 |
156 | NTRK3 | 0.25467714 |
157 | CDK9 | 0.25317189 |
158 | PKN1 | 0.25279289 |
159 | OBSCN | 0.24055655 |
160 | PRPF4B | 0.23909919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.11411769 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92016645 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90000028 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.77082694 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43985739 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31215947 |
7 | Malaria_Homo sapiens_hsa05144 | 2.30518350 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28669869 |
9 | Asthma_Homo sapiens_hsa05310 | 2.25834182 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21593918 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16295785 |
12 | Pertussis_Homo sapiens_hsa05133 | 2.13242753 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11458964 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04639440 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91362353 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90940609 |
17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.90256740 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.89748641 |
19 | Measles_Homo sapiens_hsa05162 | 1.88248655 |
20 | Gap junction_Homo sapiens_hsa04540 | 1.87889376 |
21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.84477930 |
22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.83367603 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81327992 |
24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78085588 |
25 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.77776682 |
26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.74478315 |
27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.72375644 |
28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.70925221 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70709849 |
30 | Focal adhesion_Homo sapiens_hsa04510 | 1.70686129 |
31 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67792709 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.66487396 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.61945064 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50261838 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50073985 |
36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.48225235 |
37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47570608 |
38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46454555 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41864306 |
40 | Platelet activation_Homo sapiens_hsa04611 | 1.41372045 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40631718 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37294841 |
43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.33297125 |
44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30742995 |
45 | Phagosome_Homo sapiens_hsa04145 | 1.30339639 |
46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28072378 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.27813958 |
48 | Long-term depression_Homo sapiens_hsa04730 | 1.25424200 |
49 | Lysosome_Homo sapiens_hsa04142 | 1.25191296 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24834319 |
51 | Influenza A_Homo sapiens_hsa05164 | 1.24731042 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23089319 |
53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.22719361 |
54 | Protein export_Homo sapiens_hsa03060 | 1.22097922 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21723737 |
56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20617507 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17488199 |
58 | Prostate cancer_Homo sapiens_hsa05215 | 1.16411255 |
59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15756232 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15116036 |
61 | Thyroid cancer_Homo sapiens_hsa05216 | 1.14416540 |
62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13486821 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13106863 |
64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12960921 |
65 | Adherens junction_Homo sapiens_hsa04520 | 1.11673773 |
66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10262099 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08539345 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05371354 |
69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03777450 |
70 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03531955 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01273428 |
72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01156005 |
73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01010351 |
74 | Glioma_Homo sapiens_hsa05214 | 1.00049951 |
75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96278332 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93849121 |
77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93538266 |
78 | Alcoholism_Homo sapiens_hsa05034 | 0.91019130 |
79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89779006 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86526527 |
81 | Shigellosis_Homo sapiens_hsa05131 | 0.85026092 |
82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84592775 |
83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83492176 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80733991 |
85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79023747 |
86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78565691 |
87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78096441 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78063134 |
89 | Hepatitis B_Homo sapiens_hsa05161 | 0.76646744 |
90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76147951 |
91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76143792 |
92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75442458 |
93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74871674 |
94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73823153 |
95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73536946 |
96 | Insulin resistance_Homo sapiens_hsa04931 | 0.72703521 |
97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72591276 |
98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72457097 |
99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72156993 |
100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71644550 |
101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71455570 |
102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71397878 |
103 | Morphine addiction_Homo sapiens_hsa05032 | 0.70439887 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.67667619 |
105 | Apoptosis_Homo sapiens_hsa04210 | 0.67644046 |
106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65921302 |
107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65766015 |
108 | Amoebiasis_Homo sapiens_hsa05146 | 0.65244030 |
109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64519623 |
110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62642228 |
111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61258605 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61257800 |
113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60955424 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60877780 |
115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60289263 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60217238 |
117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60081182 |
118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59942272 |
119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58922376 |
120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58822783 |
121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57609940 |
122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57550457 |
123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57160646 |
124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56864276 |
125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55961416 |
126 | Melanoma_Homo sapiens_hsa05218 | 0.52952111 |
127 | Bladder cancer_Homo sapiens_hsa05219 | 0.52898334 |
128 | Prion diseases_Homo sapiens_hsa05020 | 0.52100415 |
129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51422359 |
130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51240509 |
131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50995240 |
132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50021244 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.49820821 |
134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49706493 |
135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49256244 |
136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49245786 |
137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48704529 |
138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48036183 |
139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47534622 |
140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46446009 |
141 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46369009 |
142 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45014470 |
143 | ABC transporters_Homo sapiens_hsa02010 | 0.44824771 |
144 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44638011 |
145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44358814 |
146 | Renin secretion_Homo sapiens_hsa04924 | 0.42753466 |
147 | Ribosome_Homo sapiens_hsa03010 | 0.42230080 |
148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41712970 |
149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41174688 |
150 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40085089 |
151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37795124 |
152 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36538225 |
153 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35622233 |
154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34753228 |
155 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32075232 |
156 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30388931 |
157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28615713 |
158 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28615260 |
159 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27941136 |
160 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27471697 |
161 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25534098 |
162 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23199074 |
163 | Purine metabolism_Homo sapiens_hsa00230 | 0.20843247 |
164 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20646297 |
165 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19523807 |
166 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19209151 |
167 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19017479 |